WallStreetZenWallStreetZen

NASDAQ: NAMS
Newamsterdam Pharma Co Nv Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Newamsterdam Pharma Co Nv revenue was $52.97M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $3.2M, down 75.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NAMS annual revenue was $47.5M, with 203.2% growth year-over-year.

NAMS past revenue growth

How has NAMS's revenue growth performed historically?

Company
586.97%
Industry
1,361.15%
Market
34.96%
NAMS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NAMS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NAMS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NAMS revenue history

Current Revenue
$51.2M
Current Earnings
-$203.7M
Current Profit Margin
-397.5%

Be the first to know when NAMS announces revenue.

NAMS Revenue History By Year

NAMS Yearly RevenueNAMS RevenueNAMS ChangeNAMS Revenue Growth
2024-12-31$47.46M$31.81M+203.16%
2023-12-31$15.66M-$93.59M-85.67%
2022-12-31$109.25MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Newamsterdam Pharma Co Nv Revenue FAQ

What was NAMS's revenue last quarter?

Newamsterdam Pharma Co Nv (NASDAQ: NAMS) reported Q1 2025 revenue of $3.24 million up 112.56% year over year. In the same quarter last year, Newamsterdam Pharma Co Nv's revenue was $1.52 million.

What was Newamsterdam Pharma Co Nv's revenue in 2024?

Newamsterdam Pharma Co Nv's annual revenue for the twelve months ending Dec 31, 2024 was $47.46 million, a 203.16% increase year over year.

How much does Newamsterdam Pharma Co Nv make in a day?

Based on Newamsterdam Pharma Co Nv annual revenue for the past four years, NAMS makes an average of $118,058.87 per day.

What was Newamsterdam Pharma Co Nv's annual revenue growth in the past year?

As of Q2 2025, Newamsterdam Pharma Co Nv's revenue has grown 586.97% year over year. This is 774.17 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Newamsterdam Pharma Co Nv's revenue in the past year totaled $52.97 million.

How much does Newamsterdam Pharma Co Nv make in a year?

Newamsterdam Pharma Co Nv's revenue by year for the past four years is:
  • Newamsterdam Pharma Co Nv's revenue for the twelve months ending Dec 31, 2024 was $47.46 million, a 203.16% increase year over year.
  • Newamsterdam Pharma Co Nv's annual revenue for Dec 31, 2023 was $15.66 million, a 85.67% decrease from 2022.
  • Newamsterdam Pharma Co Nv's annual revenue for 2022 was $109.25 million, a Infinity% increase from 2021.
  • Newamsterdam Pharma Co Nv's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.